Surface-guided radiotherapy overview: Technical aspects and clinical applications.

21 Aug 2023 | Discover home page, Discover RADOPT

Surface-guided radiotherapy overview: Technical aspects and clinical applications. Breast, IGRT, Pelvis, Surface-guided radiotherapy, Image-guided radiotherapy, SGRT. Luc Simon  Team  RADOPT : Radiotherapy Optimising: from molecular signalling pathways to clinical...

Autophagy contributes to resistance to ruxolitinib in myeloproliferative neoplasms

25 Jul 2023 | Discover home page, Discover METAML

Autophagy contributes to resistance to ruxolitinib in myeloproliferative neoplasms Autophagy, Protein Phosphatase 2A, Myeloproliferative neoplasms. Carine Joffre and Véronique De-Mas team METAML : Metabolism and Therapeutic Resistance In Acute Myeloid Leukemia The...

CD36 drives metastasis and relapse in acute myeloid leukemia

18 Jul 2023 | Discover home page, Discover METAML

CD36 drives metastasis and relapse in acute myeloid leukemia Acute myeloid leukemia,  metastasis, CD36, relapse. Thomas Farge , Jean Nakhle audrey Carrière-Pazat Team METAML : Metabolism and Therapeutic Resistance In Acute Myeloid Leukemiaet METABOLINK of Restore...

A computational model of the formation of cells limiting the effect of promising cancer therapies

3 Jul 2023 | Discover home page, Discover NetB(IO)²

A computational model of the formation of cells limiting the effect of promising cancer therapies Cancer, Computational bioinformatics, systems biology; Health sciences; Immunology mathematical models for health. Véra Pancaldi Team NetB(IO)² : Network Biology for...

Cancer under pressure: which signals are activated?

30 Jun 2023 | Discover home page, Discover SigDyn

Cancer under pressure: which signals are activated? mechanical forces, cancer, mechanosensing,  compression, confinement,  targeted therapies,  cell signaling. Julie Guillermet-Guibert Team SigDyn Integrated cellular signalling and PI3K isoforms In living organisms,...

Cancer: a key mechanism for improving immunotherapies identified by a Toulouse team

30 Jun 2023 | Discover GENIM, Discover home page

Cancer: a key mechanism for improving immunotherapies identified by a Toulouse team Cancer, Immunology, Immunotherapy, Lymphocytes, Depletion. Ludovic Martinet Team GENIM Genomic and immunology of myeloma A team from the Centre de Recherches en Cancérologie de...